Effects of Estrogen on Beta-Amyloid-Induced Cholinergic Cell Death in the Nucleus Basalis Magnocellularis
Authors:
- Éva M. SzegőÉSÉva M. Szegő
- Attila CsorbaACAttila Csorba
- Tamás JanákyTJTamás Janáky
- Katalin A. KékesiKKKatalin A. Kékesi
- István M. ÁbrahámIÁIstván M. Ábrahám
- Gábor M. MórotzGMGábor M. Mórotz
- Botond PenkeBPBotond Penke
- Miklós PalkovitsMPMiklós Palkovits
- Ünige MurvaiÜMÜnige Murvai
- Miklós S.Z. KellermayerMKMiklós S.Z. Kellermayer
- József KardosJKJózsef Kardos
- Gábor D. JuhászGJGábor D. Juhász
- 8 October 2010
- journal article
- research article
- Published by S. Karger AG in Neuroendocrinology
- Vol. 93 (2) , 90-105
Abstract
Alzheimer disease is characterized by accumulation of β-amyloid (Aβ) and cognitive dysfunctions linked to early loss of cholinergic neurons. As estrogen-based hormone replacement therapy has beneficial effects on cognition of demented patients, and it may prevent memory impairments, we investigated the effect of estrogen-pretreatment on Aβ-induced cholinergic neurodegeneration in the nucleus basalis magnocellularis (NBM). We tested which Aβ species induces the more pronounced cholinotoxic effect in vivo. We injected different Aβ assemblies in the NBM of mice, and measured cholinergic cell and cortical fiber loss. Spherical Aβ oligomers had the most toxic effect. Pretreatment of ovariectomized mice with estrogen before Aβ injection decreased cholinergic neuron loss and partly prevented fiber degeneration. By using proteomics, we searched for proteins involved in estrogen-mediated protection and in Aβ toxicity 24 h following injection. The change in expression of, e.g., DJ-1, NADH ubiquinone oxidoreductase, ATP synthase, phosphatidylethanolamine-binding protein 1, protein phosphatase 2A and dimethylarginine dimethylaminohydrolase 1 support our hypothesis that Aβ induces mitochondrial dysfunction, decreases MAPK signaling, and increases NOS activation in NBM. On the other hand, altered expression of, e.g., MAP kinase kinase 1 and 2, protein phosphatase 1 and 2A by Aβ might increase MAPK suppression and NOS signaling in the cortical target area. Estrogen pretreatment reversed most of the changes in the proteome in both areas. Our experiments suggest that regulation of the MAPK pathway, mitochondrial pH and NO production may all contribute to Aβ toxicity, and their regulation can be prevented partly by estrogen pretreatment.Keywords
This publication has 74 references indexed in Scilit:
- Preclinical Alzheimer disease: Brain oxidative stress, Aβ peptide and proteomicsNeurobiology of Disease, 2010
- Amyloid-β and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease miceProceedings of the National Academy of Sciences, 2009
- Protective actions of sex steroid hormones in Alzheimer’s diseaseFrontiers in Neuroendocrinology, 2009
- Role of protein phosphatases and mitochondria in the neuroprotective effects of estrogensFrontiers in Neuroendocrinology, 2009
- Estradiol rescues neurons from global ischemia-induced cell death: Multiple cellular pathways of neuroprotectionSteroids, 2009
- Rapid Label-Free Identification of Estrogen-Induced Differential Protein ExpressionIn Vivofrom Mouse Brain and Uterine TissueJournal of Proteome Research, 2009
- Estrogen regulation of glucose metabolism and mitochondrial function: Therapeutic implications for prevention of Alzheimer's diseaseAdvanced Drug Delivery Reviews, 2008
- Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memoryNature Medicine, 2008
- Natural oligomers of the amyloid-β protein specifically disrupt cognitive functionNature Neuroscience, 2004
- Pathways towards and away from Alzheimer's diseaseNature, 2004